In Utero Exposure to the 1982 Tylenol Recall and Neurodevelopmental Outcomes
Observational research into the relationship between maternal acetaminophen use during pregnancy and a child’s subsequent risk of attention deficit hyperactivity disorder (ADHD) or autism has been limited by confounding factors. Using two large national U.S. insurance claims databases and a novel natural experiment, we assessed differences in prevalence of ADHD and autism among children whose gestational periods were impacted by a nationwide Tylenol recall issued in 1982, following deaths from Tylenol capsules containing potassium cyanide. Prevalence of ADHD and autism was not significantly different in birth cohorts exposed to the recall during gestation, when maternal acetaminophen use would have been reduced; interrupted time series models showed no significant differences compared to underlying temporal diagnostic trends. These findings are inconsistent with a clinically meaningful effect of maternal acetaminophen use on subsequent development of neurodevelopmental disorders.
-
-
Copy CitationChristopher M. Worsham, Charles Bray, Joshua Rothman, Brian Kwan, and Anupam Jena, "In Utero Exposure to the 1982 Tylenol Recall and Neurodevelopmental Outcomes," NBER Working Paper 35873 (2026), https://doi.org/10.3386/w35873.Download Citation
Related
Programs
More from the NBER
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals—the NBER Reporter, the NBER Digest, the Bulletin on Health, the Bulletin on the Economics of Alzheimer's, and the Bulletin on Entrepreneurship—as well as research spotlights, lectures, and panel videos.
